search
Back to results

Effect and Feasibility of Non-linear Periodized Resistance Training in People With COPD

Primary Purpose

Pulmonary Disease, Chronic Obstructive

Status
Recruiting
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Non-linear Periodized Resistance Training
Resistance training
Sponsored by
Umeå University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pulmonary Disease focused on measuring Muscle dysfunction

Eligibility Criteria

40 Years - 89 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • FEV1/FVC ratio < 70% postbronchodilator
  • FEV1 <80% of the predicted normal value postbronchodilator

Exclusion Criteria:

  • Clinical evidence of asthma, cardiovascular diseases, and/or neuromuscular diseases that are unstable and/or that may contribute to exercise limitation
  • Other contraindications to exercise
  • Currently participating in a structured exercise or pulmonary rehabilitation program or been involved in pulmonary rehabilitation in the past 6 months
  • Experienced a COPD exacerbation and/or change in medication dosage/frequency in the past 6 weeks

Sites / Locations

  • Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de QuebecRecruiting
  • Merem Pulmonary Rehabilitation CentreRecruiting
  • Radboud UMC
  • Umeå UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Non-linear Periodized Resistance Training

Resistance Training

Arm Description

The objective of the Non-linear Periodized Resistance Training (NLPRT) program is to increase muscle strength as well as muscle endurance. The NLPRT program will over the 8 week intervention period target several different aspects of limb muscle function, by alternating the intensity and volume of the exercises. Progression of exercise is symptom dependent and will be based on Borg CR-10 ratings (dyspnea, muscle fatigue and exertion). All exercises will be performed using exercise equipment that are available at each included center. All sessions are supervised and conducted by local professionals using a group format, with approximately 2-4 participants per group.

The primary objective of the Resistance training (RT) group is to increase muscular strength. The RT program will be performed in line with current guidelines that are recommended for increasing muscular strength in patients with COPD. Progression of exercise is performance dependent and will be based on the previous 2 sessions. All exercises will be performed using exercise equipment that are available at each included center. All sessions are supervised and conducted by local professionals using a group format, with approximately 2-4 participants per group.

Outcomes

Primary Outcome Measures

Change from baseline dynamic maximal endurance at week 9
Maximal limb muscle endurance measured using resistance training machines or free weights. Reported as the number of repetitions at 45% of the baseline one repetition maximum.
Change from baseline dynamic maximal strength at week 9
Maximal limb muscle strength measured using resistance training machines or free weights. Reported as one repetition max in kg.

Secondary Outcome Measures

Change from baseline static maximal endurance at week 9
Maximal limb muscle endurance measured using a computerized dynamometer or strain gauge. Reported in seconds maintaining 60% of the isometric maximal voluntary contraction.
Change from baseline static maximal strength at week 9
Maximal limb muscle strength measured using a computerized dynamometer or strain gauge. Reported in Nm
Change from baseline unsupported upper limb test (UULEX) at week 9
The UULEX is a progressive test where the participants will be asked to a raise plastic bar from the hip to the UULEX eight-level chart with a cadence of 30 movements per minute. If a patient reaches the highest level, the plastic bar will be replaced by a heavier one every minute. There are five different bar weights (0.2, 0.5, 1, 1.5, 2 Kg) and participants will continue on the highest level until symptom limitation. Results are reported in seconds.
Change from baseline endurance shuttle walk test (ESWT) at week 9
The ESWT is a derivative of the Incremental shuttle walk test (ISWT), where patients walk for as long as possible at a predetermined percentage of maximum walking performance as assessed by the ISWT on a 10 meter course. Reported in seconds to termination of the test or total meters walked.
Change from baseline 60 seconds sit to stand test (60STS) at week 9
During the 60STS, participants will be instructed to fully stand up and sit down as fast as possible, as many times as possible within 60 seconds. Arms will be held fold across the chest with feet remaining in full contact with the floor. Reported as the number of repetitions performed within 60 seconds.
Change From Baseline Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Total Scores at week 9
The CRQ-SAS is a self-administered questionnaire which consist of 20 items across four domains: dyspnea (5 items), fatigue (4 items), emotional function (7 items), and mastery (4 items). Participants rates their experience on a 7-point scale in response to each item ranging from 1 (maximum impairment) to 7 (no impairment). Individual items are equally weighted, and total score ranges from 20 to 140 (20 maximum impairment, 140 no impairment).
Change From Baseline Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) dyspnea Domain Scores at week 9
Domain scores are calculated as the mean of all items (5) within the dyspnea domain. Participants rates their experience on a 7-point scale in response to each item ranging from 1 (maximum impairment) to 7 (no impairment). Individual items are equally weighted, and total score ranges from 7 to 35 (7 maximum dyspnea, 35 no dyspnea).
Number of responders
The total amount of responders i.e. defined as a response over the known minimal detectable change/or minimal important difference for included test(s) will be determined and compared.
Attendance rate
Attendance rate will be evaluated by calculating the number of attended sessions divided by total number of sessions for each participant
Duration of exercise sessions
Mean time in minutes of exercise sessions
Satisfaction rate
Participant satisfaction with the exercise regimens will be recorded by adapting an existing patient satisfaction questionnaire. Participants rate their satisfaction on 7 items each with a 5 point likert scale. Results using the total score (0-35, higher score indicating higher satisfaction).
Proportion of drop-outs
Proportion of participants that don't complete the intervention
Adverse Events rate
Occurrence of any adverse events. An adverse event rate will be calculated for each patient as the total number of sessions during which any adverse events occurred divided by the total number of attended sessions.
Adverse Events stratified by severity
The severity of the adverse events will be assessed and rated into four different categories: 1) minor and temporary, 2) serious symptoms (potential risk of severe injury or life threatening), 3) manifest injury or disease, and 4) death. Presented in factual numbers for each group.
Change from baseline muscle fiber size at week 9
The tissue sample obtained from the vastus lateralis muscle will be examined with morphometric analyses to determine cross-sectional fiber area. Reported in square micrometers.
Change from baseline proportion of slow and fast subtypes of contractile myosin heavy chain isoforms in fibers at week 9
The tissue sample obtained from the vastus lateralis muscle will be examined with immunohistochemistry techniques to categorize fiber types.
Change from baseline oxidative (citrate synthase (CS), EC 4.1.3.7) enzyme activities at week 9
The tissue sample obtained from the vastus lateralis muscle will be examined to demonstrate enzyme activities. Reported in micromol/min/g tissue. [Time Frame: Baseline and week 9] The tissue sample obtained from the vastus lateralis muscle will be examined by histochemistry to demonstrate enzyme activities. Reported in micromol/min/g tissue.
Change from baseline glycolytic (lactate dehydrogenase (LDH), EC 1.1.1.27) enzyme activities at week 9
The tissue sample obtained from the vastus lateralis muscle will be examined to demonstrate enzyme activities. Reported in micromol/min/g tissue.
Change from baseline capillarization (capillary density) at week 9
The tissue sample obtained from the vastus lateralis muscle will be examined with morphometric analysis to determine capillary density, estimated as the total number of capillaries per millimeter squared muscle cross-section.
Change from baseline capillarization (capillaries to fiber) at week 9
The tissue sample obtained from the vastus lateralis muscle will be examined with morphometric analysis to determine the number of capillaries around fibers including all capillaries in contact with each muscle fiber.
Change from baseline capillarization (capillaries relative to fiber area) at week 9
The tissue sample obtained from the vastus lateralis muscle will be examined with morphometric analysis to determine the number of capillaries around each fiber relative to its cross-sectional area.

Full Information

First Posted
April 13, 2018
Last Updated
November 1, 2022
Sponsor
Umeå University
Collaborators
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Radboud University Medical Center, Merem Pulmonary Rehabilitation Centre
search

1. Study Identification

Unique Protocol Identification Number
NCT03518723
Brief Title
Effect and Feasibility of Non-linear Periodized Resistance Training in People With COPD
Official Title
Effect and Feasibility of Non-linear Periodized Resistance Training in People With Chronic Obstructive Pulmonary Disease: a Randomized Controlled Multicenter Trial
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
April 16, 2018 (Actual)
Primary Completion Date
December 2022 (Anticipated)
Study Completion Date
December 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Umeå University
Collaborators
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Radboud University Medical Center, Merem Pulmonary Rehabilitation Centre

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims at improving the knowledge about resistance training for people with COPD. Resistance training is an important part of pulmonary rehabilitation when the goal is to improve muscular endurance and strength. The study will evaluate the effects and the feasibility of two resistance training programs for people with COPD using a parallel group design. One program will include a larger day-to-day variation (i.e. non-linear periodization) and the progression will be guided by ratings of dyspnea, muscle fatigue, and exertion. The other program will follow the established guidelines for resistance training for people with COPD. The programs will be evaluated for effects regarding muscular endurance, strength, intramuscular adaptions, functional preformance, dyspnea, and health related quality of life. The programs will also be evaluated for feasibility regarding the duration of training sessions, attendance rates, adverse events, and participant satisfaction. The hypothesis is that the non-linear periodization group will have superior effects and that feasibility aspects will be similar between groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Disease, Chronic Obstructive
Keywords
Muscle dysfunction

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Prospective, assessor-blind, parallel-group randomized controlled multicenter trial with a pre- and post-intervention design
Masking
Outcomes Assessor
Masking Description
The outcome assessors will be masked to group allocation. The participants will be given repeated instructions not to reveal their group allocation to the outcome assessors. In case of failure in keeping the outcome assessor masked (i.e, a patient reveals his/her group allocation), a second trained outcome assessor will be available.
Allocation
Randomized
Enrollment
64 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Non-linear Periodized Resistance Training
Arm Type
Experimental
Arm Description
The objective of the Non-linear Periodized Resistance Training (NLPRT) program is to increase muscle strength as well as muscle endurance. The NLPRT program will over the 8 week intervention period target several different aspects of limb muscle function, by alternating the intensity and volume of the exercises. Progression of exercise is symptom dependent and will be based on Borg CR-10 ratings (dyspnea, muscle fatigue and exertion). All exercises will be performed using exercise equipment that are available at each included center. All sessions are supervised and conducted by local professionals using a group format, with approximately 2-4 participants per group.
Arm Title
Resistance Training
Arm Type
Active Comparator
Arm Description
The primary objective of the Resistance training (RT) group is to increase muscular strength. The RT program will be performed in line with current guidelines that are recommended for increasing muscular strength in patients with COPD. Progression of exercise is performance dependent and will be based on the previous 2 sessions. All exercises will be performed using exercise equipment that are available at each included center. All sessions are supervised and conducted by local professionals using a group format, with approximately 2-4 participants per group.
Intervention Type
Other
Intervention Name(s)
Non-linear Periodized Resistance Training
Intervention Description
8 week non-linear periodized resistance training intervention, 3 sessions per week, 60 minutes per session
Intervention Type
Other
Intervention Name(s)
Resistance training
Intervention Description
8 week resistance training intervention, 3 sessions per week, 60 minutes per session
Primary Outcome Measure Information:
Title
Change from baseline dynamic maximal endurance at week 9
Description
Maximal limb muscle endurance measured using resistance training machines or free weights. Reported as the number of repetitions at 45% of the baseline one repetition maximum.
Time Frame
Baseline and week 9
Title
Change from baseline dynamic maximal strength at week 9
Description
Maximal limb muscle strength measured using resistance training machines or free weights. Reported as one repetition max in kg.
Time Frame
Baseline and week 9
Secondary Outcome Measure Information:
Title
Change from baseline static maximal endurance at week 9
Description
Maximal limb muscle endurance measured using a computerized dynamometer or strain gauge. Reported in seconds maintaining 60% of the isometric maximal voluntary contraction.
Time Frame
Baseline and week 9
Title
Change from baseline static maximal strength at week 9
Description
Maximal limb muscle strength measured using a computerized dynamometer or strain gauge. Reported in Nm
Time Frame
Baseline and week 9
Title
Change from baseline unsupported upper limb test (UULEX) at week 9
Description
The UULEX is a progressive test where the participants will be asked to a raise plastic bar from the hip to the UULEX eight-level chart with a cadence of 30 movements per minute. If a patient reaches the highest level, the plastic bar will be replaced by a heavier one every minute. There are five different bar weights (0.2, 0.5, 1, 1.5, 2 Kg) and participants will continue on the highest level until symptom limitation. Results are reported in seconds.
Time Frame
Baseline and week 9
Title
Change from baseline endurance shuttle walk test (ESWT) at week 9
Description
The ESWT is a derivative of the Incremental shuttle walk test (ISWT), where patients walk for as long as possible at a predetermined percentage of maximum walking performance as assessed by the ISWT on a 10 meter course. Reported in seconds to termination of the test or total meters walked.
Time Frame
Baseline and week 9
Title
Change from baseline 60 seconds sit to stand test (60STS) at week 9
Description
During the 60STS, participants will be instructed to fully stand up and sit down as fast as possible, as many times as possible within 60 seconds. Arms will be held fold across the chest with feet remaining in full contact with the floor. Reported as the number of repetitions performed within 60 seconds.
Time Frame
Baseline and week 9
Title
Change From Baseline Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Total Scores at week 9
Description
The CRQ-SAS is a self-administered questionnaire which consist of 20 items across four domains: dyspnea (5 items), fatigue (4 items), emotional function (7 items), and mastery (4 items). Participants rates their experience on a 7-point scale in response to each item ranging from 1 (maximum impairment) to 7 (no impairment). Individual items are equally weighted, and total score ranges from 20 to 140 (20 maximum impairment, 140 no impairment).
Time Frame
Baseline and week 9
Title
Change From Baseline Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) dyspnea Domain Scores at week 9
Description
Domain scores are calculated as the mean of all items (5) within the dyspnea domain. Participants rates their experience on a 7-point scale in response to each item ranging from 1 (maximum impairment) to 7 (no impairment). Individual items are equally weighted, and total score ranges from 7 to 35 (7 maximum dyspnea, 35 no dyspnea).
Time Frame
Baseline and week 9
Title
Number of responders
Description
The total amount of responders i.e. defined as a response over the known minimal detectable change/or minimal important difference for included test(s) will be determined and compared.
Time Frame
Week 9
Title
Attendance rate
Description
Attendance rate will be evaluated by calculating the number of attended sessions divided by total number of sessions for each participant
Time Frame
Week 1 up to 8
Title
Duration of exercise sessions
Description
Mean time in minutes of exercise sessions
Time Frame
Week 1 up to 8
Title
Satisfaction rate
Description
Participant satisfaction with the exercise regimens will be recorded by adapting an existing patient satisfaction questionnaire. Participants rate their satisfaction on 7 items each with a 5 point likert scale. Results using the total score (0-35, higher score indicating higher satisfaction).
Time Frame
Week 9
Title
Proportion of drop-outs
Description
Proportion of participants that don't complete the intervention
Time Frame
Week 9
Title
Adverse Events rate
Description
Occurrence of any adverse events. An adverse event rate will be calculated for each patient as the total number of sessions during which any adverse events occurred divided by the total number of attended sessions.
Time Frame
Week 1 up to 8
Title
Adverse Events stratified by severity
Description
The severity of the adverse events will be assessed and rated into four different categories: 1) minor and temporary, 2) serious symptoms (potential risk of severe injury or life threatening), 3) manifest injury or disease, and 4) death. Presented in factual numbers for each group.
Time Frame
Week 1 up to 8
Title
Change from baseline muscle fiber size at week 9
Description
The tissue sample obtained from the vastus lateralis muscle will be examined with morphometric analyses to determine cross-sectional fiber area. Reported in square micrometers.
Time Frame
Baseline and week 9
Title
Change from baseline proportion of slow and fast subtypes of contractile myosin heavy chain isoforms in fibers at week 9
Description
The tissue sample obtained from the vastus lateralis muscle will be examined with immunohistochemistry techniques to categorize fiber types.
Time Frame
Baseline and week 9
Title
Change from baseline oxidative (citrate synthase (CS), EC 4.1.3.7) enzyme activities at week 9
Description
The tissue sample obtained from the vastus lateralis muscle will be examined to demonstrate enzyme activities. Reported in micromol/min/g tissue. [Time Frame: Baseline and week 9] The tissue sample obtained from the vastus lateralis muscle will be examined by histochemistry to demonstrate enzyme activities. Reported in micromol/min/g tissue.
Time Frame
Baseline and week 9
Title
Change from baseline glycolytic (lactate dehydrogenase (LDH), EC 1.1.1.27) enzyme activities at week 9
Description
The tissue sample obtained from the vastus lateralis muscle will be examined to demonstrate enzyme activities. Reported in micromol/min/g tissue.
Time Frame
Baseline and week 9
Title
Change from baseline capillarization (capillary density) at week 9
Description
The tissue sample obtained from the vastus lateralis muscle will be examined with morphometric analysis to determine capillary density, estimated as the total number of capillaries per millimeter squared muscle cross-section.
Time Frame
Baseline and week 9
Title
Change from baseline capillarization (capillaries to fiber) at week 9
Description
The tissue sample obtained from the vastus lateralis muscle will be examined with morphometric analysis to determine the number of capillaries around fibers including all capillaries in contact with each muscle fiber.
Time Frame
Baseline and week 9
Title
Change from baseline capillarization (capillaries relative to fiber area) at week 9
Description
The tissue sample obtained from the vastus lateralis muscle will be examined with morphometric analysis to determine the number of capillaries around each fiber relative to its cross-sectional area.
Time Frame
Baseline and week 9

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
89 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: FEV1/FVC ratio < 70% postbronchodilator FEV1 <80% of the predicted normal value postbronchodilator Exclusion Criteria: Clinical evidence of asthma, cardiovascular diseases, and/or neuromuscular diseases that are unstable and/or that may contribute to exercise limitation Other contraindications to exercise Currently participating in a structured exercise or pulmonary rehabilitation program or been involved in pulmonary rehabilitation in the past 6 months Experienced a COPD exacerbation and/or change in medication dosage/frequency in the past 6 weeks
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Andre Nyberg, PhD
Phone
+46(0)907866639
Email
andre.nyberg@umu.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andre Nyberg, PhD
Organizational Affiliation
Umeå University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
City
Québec City
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Didier Saey, PhD
Email
didier.saey@rea.ulaval.ca
First Name & Middle Initial & Last Name & Degree
François Maltais, PhD
First Name & Middle Initial & Last Name & Degree
Didier Saey, PhD
Facility Name
Merem Pulmonary Rehabilitation Centre
City
Hilversum
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Peter Klijn, PhD
Email
PKlijn@merem.nl
First Name & Middle Initial & Last Name & Degree
Peter Klijn, PhD
Facility Name
Radboud UMC
City
Nijmegen
Country
Netherlands
Individual Site Status
Withdrawn
Facility Name
Umeå University
City
Umeå
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Andre Nyberg, PhD
Email
andre.nyberg@umu.se
First Name & Middle Initial & Last Name & Degree
Andre Nyberg, PhD

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
30606240
Citation
Frykholm E, Klijn P, Saey D, van Hees HWH, Stal P, Sandstrom T, Sorlin A, Maltais F, Nyberg A. Effect and feasibility of non-linear periodized resistance training in people with COPD: study protocol for a randomized controlled trial. Trials. 2019 Jan 3;20(1):6. doi: 10.1186/s13063-018-3129-y.
Results Reference
derived

Learn more about this trial

Effect and Feasibility of Non-linear Periodized Resistance Training in People With COPD

We'll reach out to this number within 24 hrs